Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-05-15 6:41 pm Sale |
2025-03-31 | 13G | Verastem, Inc. VSTM |
ORBIMED ADVISORS LLC | 2,862,448 5.600% |
-1,286,414 (-31.01%) |
Filing History |
| 2025-05-15 4:39 pm Purchase |
2025-03-31 | 13G | Verastem, Inc. VSTM |
Nantahala Capital Management, LLC | 5,459,278 9.990% |
936,094 (+20.70%) |
Filing History |
| 2025-05-15 08:07 am Purchase |
2025-03-31 | 13G | Verastem, Inc. VSTM |
RTW Investments, LP | 4,245,476 8.300% |
4,245,476 (New Position) |
Filing History |
| 2025-05-15 06:05 am Purchase |
2025-03-31 | 13G | Verastem, Inc. VSTM |
Balyasny Asset Management L.P. | 4,787,975 9.300% |
842,048 (+21.34%) |
Filing History |
| 2025-05-02 5:00 pm Sale |
2025-03-31 | 13G | Verastem, Inc. VSTM |
Soleus Private Equity Fund III, L.P. | 935,819 1.800% |
-3,058,810 (-76.57%) |
Filing History |
| 2025-04-30 11:13 am Purchase |
2025-03-31 | 13G | Verastem, Inc. VSTM |
The Vanguard Group | 2,430,110 4.710% |
118,596 (+5.13%) |
Filing History |
| 2025-04-24 11:26 am Purchase |
2025-03-31 | 13G | Verastem, Inc. VSTM |
BlackRock Inc. BLK |
2,518,642 4.900% |
283,943 (+12.71%) |
Filing History |
| 2025-03-21 5:05 pm Unchanged |
2024-12-31 | 13G | Verastem, Inc. VSTM |
BARCLAYS PLC | 3,949,801 8.870% |
0 (Unchanged) |
Filing History |
| 2025-02-14 4:32 pm Purchase |
2024-12-31 | 13G | Verastem, Inc. VSTM |
Nantahala Capital Management, LLC | 4,523,184 9.990% |
470,980 (+11.62%) |
Filing History |
| 2025-02-14 4:26 pm Purchase |
2024-12-31 | 13G | Verastem, Inc. VSTM |
BIOTECHNOLOGY VALUE FUND L P | 4,706,551 9.990% |
427,030 (+9.98%) |
Filing History |
| 2025-02-14 4:22 pm Sale |
2024-12-31 | 13G | Verastem, Inc. VSTM |
Alyeska Investment Group, L.P. | 1,000,000 2.100% |
-1,859,954 (-65.03%) |
Filing History |
| 2025-02-14 2:26 pm Purchase |
2024-12-31 | 13G | Verastem, Inc. VSTM |
BARCLAYS PLC | 3,949,801 8.870% |
3,949,801 (New Position) |
Filing History |
| 2025-02-14 07:27 am Purchase |
2024-12-31 | 13G | Verastem, Inc. VSTM |
Balyasny Asset Management L.P. | 3,945,927 8.870% |
3,945,927 (New Position) |
Filing History |
| 2025-02-13 12:32 pm Sale |
2024-12-31 | 13G | Verastem, Inc. VSTM |
Stonepine Capital Management, LLC | 2,203,333 4.800% |
-440,287 (-16.65%) |
Filing History |
| 2025-02-11 4:00 pm Purchase |
2024-12-31 | 13G | Verastem, Inc. VSTM |
Soleus Capital Master Fund, L.P. | 3,350,692 7.300% |
1,925,058 (+135.03%) |
Filing History |
| 2025-01-31 10:08 am Purchase |
2024-12-31 | 13G | Verastem, Inc. VSTM |
The Vanguard Group | 2,311,514 5.190% |
2,311,514 (New Position) |
Filing History |
| 2025-01-21 11:57 am Purchase |
2024-12-31 | 13G | Verastem, Inc. VSTM |
Orin Hirschman | 2,717,827 6.100% |
2,717,827 (New Position) |
Filing History |
| 2024-11-14 6:25 pm Purchase |
2024-09-30 | 13G | Verastem, Inc. VSTM |
ORBIMED ADVISORS LLC | 4,148,862 9.900% |
2,619,747 (+171.32%) |
Filing History |
| 2024-11-14 4:53 pm Purchase |
2024-09-30 | 13G | Verastem, Inc. VSTM |
Nantahala Capital Management, LLC | 4,052,204 9.990% |
4,052,204 (New Position) |
Filing History |
| 2024-11-14 4:38 pm Purchase |
2024-09-30 | 13G | Verastem, Inc. VSTM |
BIOTECHNOLOGY VALUE FUND L P | 4,279,521 9.990% |
1,662,119 (+63.50%) |
Filing History |